首页 > 最新文献

Journal of Steroid Biochemistry and Molecular Biology最新文献

英文 中文
Therapeutic potential of enzymes, neurosteroids, and synthetic steroids in neurodegenerative disorders: A critical review 酶、神经类固醇和合成类固醇在神经退行性疾病中的治疗潜力:综述
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-25 DOI: 10.1016/j.jsbmb.2025.106766
Refik Servi , Ramazan Fazıl Akkoç , Feyza Aksu , Süleyman Servi
<div><div>Neurodegenerative disorders present a significant challenge to healthcare systems, mainly due to the limited availability of effective treatment options to halt or reverse disease progression. Endogenous steroids synthesized in the central nervous system, such as pregnenolone (PREG), dehydroepiandrosterone (DHEA), progesterone (PROG), and allopregnanolone (ALLO), have been identified as potential therapeutic agents for neurodegenerative diseases. Neurosteroids such as ALLO, DHEA, and PROG, as well as their synthetic analogs like Ganaxolene, Fluasterone, and Olexoxime, offer promising effects for conditions such as Alzheimer's disease (AD) and depression. Moreover, Brexanolone and Ganaxolone are synthetic steroids approved for the treatment of postpartum depression and epilepsy, respectively. Neurosteroids such as ALLO are crucial in modulating GABAergic neurotransmission and reducing neuroinflammation. These compounds enhance the activity of GABA-A receptors, leading to increased inhibitory signaling in the brain, which can help regulate mood, cognition, and neuroprotection. Small clinical trials and observational studies indicate that ALLO may have cognitive benefits, but no large-scale, definitive meta-analysis confirms a 20 % improvement in AD patients. Mitochondrial dysfunction plays a vital role in the pathogenesis of numerous neurological diseases due to the high-energy demand and sensitivity of neurons to oxidative stress. Reduced mitochondrial function leads to amyloid-beta plaques and tau tangles accumulation in AD. In Parkinson's disease (PD), mitochondrial dysfunction resulting from the PINK1 or Parkin genes leads to energy deficiencies and the accumulation of toxic byproducts. Mutations in genes such as SOD1, C9orf72, and TDP-43 have been associated with mitochondrial dysfunction in amyotrophic lateral sclerosis (ALS). Moreover, studies on these neurodegenerative diseases suggest that inflammation is not merely a consequence of neurodegeneration but is also an essential factor in this process. Many neurological disorders involve multifaceted interactions between genetics, the environment, and immune responses, making it difficult to pinpoint their exact causes. Future research aims to overcome these hurdles through genetic advances, regenerative medicine, and personalized therapies. Cutting-edge technologies such as artificial intelligence and high-throughput screening are expected to accelerate drug discovery and improve diagnostic accuracy. Increasing collaboration between interdisciplinary fields such as bioinformatics, neuroscience, and immunology will lead to innovative treatment strategies. This comprehensive review discusses the therapeutic effects of enzymes, neurosteroids, and synthetic steroids in different neurodegenerative diseases, particularly AD, PD, ALS, and MS. Potential challenges in the therapeutic use of neurosteroids, such as the limited bioavailability and off-target effects of synthetic steroids, are a
神经退行性疾病对卫生保健系统提出了重大挑战,主要是因为阻止或逆转疾病进展的有效治疗方案的可用性有限。中枢神经系统合成的内源性类固醇,如孕烯醇酮(PREG)、脱氢表雄酮(DHEA)、孕酮(PROG)和异孕烯醇酮(ALLO),已被确定为神经退行性疾病的潜在治疗药物。神经类固醇如ALLO、DHEA和PROG,以及它们的合成类似物如Ganaxolene、Fluasterone和olexex肟,对阿尔茨海默病(AD)和抑郁症等疾病有很好的疗效。此外,Brexanolone和Ganaxolone是分别被批准用于治疗产后抑郁症和癫痫的合成类固醇。神经类固醇如ALLO在调节gaba能神经传递和减少神经炎症中起着至关重要的作用。这些化合物增强GABA-A受体的活性,导致大脑中抑制性信号的增加,这有助于调节情绪、认知和神经保护。小型临床试验和观察性研究表明,ALLO可能具有认知益处,但没有大规模、明确的荟萃分析证实,ALLO对AD患者有20% %的改善。由于神经元对氧化应激的高能量需求和敏感性,线粒体功能障碍在许多神经系统疾病的发病机制中起着至关重要的作用。线粒体功能降低导致AD中淀粉样斑块和tau缠结的积累。在帕金森病(PD)中,由PINK1或Parkin基因引起的线粒体功能障碍导致能量不足和有毒副产物的积累。SOD1、C9orf72和TDP-43等基因突变与肌萎缩性侧索硬化症(ALS)的线粒体功能障碍有关。此外,对这些神经退行性疾病的研究表明,炎症不仅是神经退行性疾病的结果,而且也是这一过程的重要因素。许多神经系统疾病涉及遗传、环境和免疫反应之间的多方面相互作用,因此很难确定其确切原因。未来的研究旨在通过基因进步、再生医学和个性化治疗来克服这些障碍。人工智能和高通量筛选等尖端技术有望加速药物发现并提高诊断准确性。生物信息学、神经科学和免疫学等跨学科领域之间的合作将带来创新的治疗策略。这篇综合综述讨论了酶、神经类固醇和合成类固醇在不同神经退行性疾病中的治疗作用,特别是AD、PD、ALS和ms。还讨论了神经类固醇治疗使用中的潜在挑战,如有限的生物利用度和合成类固醇的脱靶效应,并介绍了这些类固醇对神经退行性疾病的最新综合综述。
{"title":"Therapeutic potential of enzymes, neurosteroids, and synthetic steroids in neurodegenerative disorders: A critical review","authors":"Refik Servi ,&nbsp;Ramazan Fazıl Akkoç ,&nbsp;Feyza Aksu ,&nbsp;Süleyman Servi","doi":"10.1016/j.jsbmb.2025.106766","DOIUrl":"10.1016/j.jsbmb.2025.106766","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Neurodegenerative disorders present a significant challenge to healthcare systems, mainly due to the limited availability of effective treatment options to halt or reverse disease progression. Endogenous steroids synthesized in the central nervous system, such as pregnenolone (PREG), dehydroepiandrosterone (DHEA), progesterone (PROG), and allopregnanolone (ALLO), have been identified as potential therapeutic agents for neurodegenerative diseases. Neurosteroids such as ALLO, DHEA, and PROG, as well as their synthetic analogs like Ganaxolene, Fluasterone, and Olexoxime, offer promising effects for conditions such as Alzheimer's disease (AD) and depression. Moreover, Brexanolone and Ganaxolone are synthetic steroids approved for the treatment of postpartum depression and epilepsy, respectively. Neurosteroids such as ALLO are crucial in modulating GABAergic neurotransmission and reducing neuroinflammation. These compounds enhance the activity of GABA-A receptors, leading to increased inhibitory signaling in the brain, which can help regulate mood, cognition, and neuroprotection. Small clinical trials and observational studies indicate that ALLO may have cognitive benefits, but no large-scale, definitive meta-analysis confirms a 20 % improvement in AD patients. Mitochondrial dysfunction plays a vital role in the pathogenesis of numerous neurological diseases due to the high-energy demand and sensitivity of neurons to oxidative stress. Reduced mitochondrial function leads to amyloid-beta plaques and tau tangles accumulation in AD. In Parkinson's disease (PD), mitochondrial dysfunction resulting from the PINK1 or Parkin genes leads to energy deficiencies and the accumulation of toxic byproducts. Mutations in genes such as SOD1, C9orf72, and TDP-43 have been associated with mitochondrial dysfunction in amyotrophic lateral sclerosis (ALS). Moreover, studies on these neurodegenerative diseases suggest that inflammation is not merely a consequence of neurodegeneration but is also an essential factor in this process. Many neurological disorders involve multifaceted interactions between genetics, the environment, and immune responses, making it difficult to pinpoint their exact causes. Future research aims to overcome these hurdles through genetic advances, regenerative medicine, and personalized therapies. Cutting-edge technologies such as artificial intelligence and high-throughput screening are expected to accelerate drug discovery and improve diagnostic accuracy. Increasing collaboration between interdisciplinary fields such as bioinformatics, neuroscience, and immunology will lead to innovative treatment strategies. This comprehensive review discusses the therapeutic effects of enzymes, neurosteroids, and synthetic steroids in different neurodegenerative diseases, particularly AD, PD, ALS, and MS. Potential challenges in the therapeutic use of neurosteroids, such as the limited bioavailability and off-target effects of synthetic steroids, are a","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106766"},"PeriodicalIF":2.7,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143877103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the effects of estrogens on endometrial cancer cells of different grades 雌激素对不同级别子宫内膜癌细胞的影响评价
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-16 DOI: 10.1016/j.jsbmb.2025.106762
Renata Pavlič, Maja Novak Pušić, Tea Lanišnik Rižner
Endometrial cancer (EC) is the most common gynecological malignancy in the Western world. The molecular basis and effects of various agents are frequently studied in model EC cell lines, but the most commonly used cell lines Ishikawa, HEC-1-A, RL95–2 and KLE have not been thoroughly and systematically investigated. We characterized EC cell lines of different grades by reassessing the expression of estrogen receptors ERα, ERβ, and GPER by qPCR and Western blot and investigated the effects of estrogens, estrone-sulfate, estrone and estradiol on their proliferation, migration, and clonogenicity. Estradiol promoted the proliferation of grade 1 Ishikawa EC cells and grade 2 RL95–2 cells. Estrone and estrone sulfate also stimulated the proliferation of Ishikawa, showed a tendency to increase the proliferation of HEC-1-A and RL95–2 cells, but decreased the proliferation of KLE. Estrogens had no effect on the migration and clonogenicity of these four EC cell lines, however, there was a trend toward a smaller colony area for cells incubated with higher estrogen concentrations. We have previously shown that in EC estradiol forms from inactive estrone sulfate via the sulfatase pathway. This study showed that estrogens significantly promote the proliferation of grade 1 Ishikawa EC cells, and grade 2 RL95–2 and decrease the proliferation of grade 3 KLE cells. These differences in proliferation were associated with ERα positivity of Ishikawa cells and GPER expression in other cells.
子宫内膜癌是西方国家最常见的妇科恶性肿瘤。各种药物的分子基础和作用在模型EC细胞系中经常被研究,但最常用的Ishikawa细胞系、HEC-1-A细胞系、RL95-2细胞系和KLE细胞系尚未得到深入和系统的研究。我们通过qPCR和Western blot技术重新评估雌激素受体ERα、ERβ和GPER的表达,对不同级别EC细胞系进行了表征,并研究了雌激素、硫酸雌酮、雌酮和雌二醇对EC细胞系增殖、迁移和克隆性的影响。雌二醇促进1级Ishikawa EC细胞和2级RL95-2细胞的增殖。雌酮和硫酸雌酮对Ishikawa细胞的增殖也有促进作用,有增加HEC-1-A和RL95-2细胞增殖的趋势,但对KLE的增殖有抑制作用。雌激素对四种EC细胞系的迁移和克隆性没有影响,但雌激素浓度越高,细胞的集落面积越小。我们以前已经表明,在EC中,雌二醇是通过磺化酶途径从无活性的雌酮硫酸形成的。本研究表明,雌激素可显著促进1级Ishikawa EC细胞和2级RL95-2细胞的增殖,并降低3级KLE细胞的增殖。这些增殖差异与石川细胞ERα阳性和其他细胞GPER表达有关。
{"title":"Evaluation of the effects of estrogens on endometrial cancer cells of different grades","authors":"Renata Pavlič,&nbsp;Maja Novak Pušić,&nbsp;Tea Lanišnik Rižner","doi":"10.1016/j.jsbmb.2025.106762","DOIUrl":"10.1016/j.jsbmb.2025.106762","url":null,"abstract":"<div><div>Endometrial cancer (EC) is the most common gynecological malignancy in the Western world. The molecular basis and effects of various agents are frequently studied in model EC cell lines, but the most commonly used cell lines Ishikawa, HEC-1-A, RL95–2 and KLE have not been thoroughly and systematically investigated. We characterized EC cell lines of different grades by reassessing the expression of estrogen receptors ERα, ERβ, and GPER by qPCR and Western blot and investigated the effects of estrogens, estrone-sulfate, estrone and estradiol on their proliferation, migration, and clonogenicity. Estradiol promoted the proliferation of grade 1 Ishikawa EC cells and grade 2 RL95–2 cells. Estrone and estrone sulfate also stimulated the proliferation of Ishikawa, showed a tendency to increase the proliferation of HEC-1-A and RL95–2 cells, but decreased the proliferation of KLE. Estrogens had no effect on the migration and clonogenicity of these four EC cell lines, however, there was a trend toward a smaller colony area for cells incubated with higher estrogen concentrations. We have previously shown that in EC estradiol forms from inactive estrone sulfate via the sulfatase pathway. This study showed that estrogens significantly promote the proliferation of grade 1 Ishikawa EC cells, and grade 2 RL95–2 and decrease the proliferation of grade 3 KLE cells. These differences in proliferation were associated with ERα positivity of Ishikawa cells and GPER expression in other cells.</div></div>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106762"},"PeriodicalIF":2.7,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143852205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Follicular fluid concentrations of the vitamin D metabolite 24,25(OH)2D3 are positively associated with live birth rate after assisted reproductive technology 辅助生殖技术后卵泡液中维生素D代谢物24,25(OH)2D3的浓度与活产率呈正相关
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-15 DOI: 10.1016/j.jsbmb.2025.106764
Ireen Kooij , Rune Holt , Li Juel Mortensen , Mette Lorenzen , Ursula Bentin-Ley , Hans Krog , Anders Hayden Berg , Anders Juul , Stine Gry Kristensen , Anne Jørgensen , Martin Blomberg Jensen

Objective

To investigate the relationship between concentrations of vitamin D metabolites in follicular fluid and outcome of assisted reproductive technology (ART) treatment.

Design

Prospective cohort study including 116 women undergoing in vitro fertilization (IVF) or intra cytoplasmic sperm injection (ICSI) treatment.

Results

All measured vitamin D metabolites 25OHD3, 1,25(OH)2D3 and 24,25(OH)2D3 are detectable in follicular fluid. Follicular fluid concentration of the 24,25(OH)2D3 metabolite was higher than corresponding serum values, while the opposite phenomenon was observed for the 1,25(OH)2D3 metabolite. Local conversion is plausible as the vitamin D activating enzymes (CYP2R1 and CYP27B1) as well as the vitamin D receptor (VDR) are highly expressed in the developing follicle. Women who achieved a live birth had 29 % higher 24,25(OH)2D3 and 15 % higher 25OHD3 concentrations in their follicular fluid (18 ± 7.9 versus 14 ± 6.2 nmol/L, p = 0.008 and 71 ± 22 versus 62 ± 18 nmol/L, p = 0.025, respectively) compared to women not achieving a live birth. Moreover, women with a low (≤ 15 %) follicular fluid 1,25(OH)2D3/24,25(OH)2D3 ratio had a higher live birth rate compared to women with a medium (16–84 %) or high (≥ 85 %) ratio (live birth rate: 53 % vs 29 % and 12 %, respectively, p = 0.032).

Conclusion

This study reveals that high levels of 24,25(OH)2D3 and low levels of the 1,25(OH)2D3/24,25(OH)2D3 ratio in follicular fluid are associated with increased live birth rates in women undergoing IVF/ICSI treatment. Conversion of vitamin D metabolites systemically or in the ovarian follicle may affect ART outcome. Further studies are warranted to support the findings from this pilot study and identify regulators of ovarian vitamin D metabolites.
目的探讨卵泡液中维生素D代谢物浓度与辅助生殖技术(ART)治疗效果的关系。前瞻性队列研究包括116名接受体外受精(IVF)或细胞质内精子注射(ICSI)治疗的妇女。结果卵泡液中维生素D代谢产物25OHD3、1,25(OH)2D3和24,25(OH)2D3均可检出。卵泡液中24,25(OH)2D3代谢物的浓度高于相应的血清值,而1,25(OH)2D3代谢物的浓度则相反。局部转化是合理的,因为维生素D激活酶(CYP2R1和CYP27B1)以及维生素D受体(VDR)在发育中的卵泡中高度表达。妇女取得了活产29 %更高的24日,25 (OH) 2 d3和浓度高出15 % 25 ohd3卵泡液(18 ± 7.9和14 ± 6.2 nmol / L p = 0.008和71 ± 22和62 ± 18 nmol / L, p = 0.025,分别)相比,女性没有实现活产。此外,卵泡液1,25(OH)2D3/24,25(OH)2D3比例低(≤15 %)的妇女的活产率高于中(16-84 %)或高(≥85 %)比例的妇女(活产率分别为53 %对29 %和12 %,p = 0.032)。结论卵泡液中高水平的24,25(OH)2D3和低水平的1,25(OH)2D3/24,25(OH)2D3比值与接受IVF/ICSI治疗的妇女的活产率升高有关。全身或卵巢卵泡内维生素D代谢物的转化可能影响ART的结果。需要进一步的研究来支持这一初步研究的发现,并确定卵巢维生素D代谢产物的调节因子。
{"title":"Follicular fluid concentrations of the vitamin D metabolite 24,25(OH)2D3 are positively associated with live birth rate after assisted reproductive technology","authors":"Ireen Kooij ,&nbsp;Rune Holt ,&nbsp;Li Juel Mortensen ,&nbsp;Mette Lorenzen ,&nbsp;Ursula Bentin-Ley ,&nbsp;Hans Krog ,&nbsp;Anders Hayden Berg ,&nbsp;Anders Juul ,&nbsp;Stine Gry Kristensen ,&nbsp;Anne Jørgensen ,&nbsp;Martin Blomberg Jensen","doi":"10.1016/j.jsbmb.2025.106764","DOIUrl":"10.1016/j.jsbmb.2025.106764","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the relationship between concentrations of vitamin D metabolites in follicular fluid and outcome of assisted reproductive technology (ART) treatment.</div></div><div><h3>Design</h3><div>Prospective cohort study including 116 women undergoing <em>in vitro</em> fertilization (IVF) or intra cytoplasmic sperm injection (ICSI) treatment.</div></div><div><h3>Results</h3><div>All measured vitamin D metabolites 25OHD<sub>3</sub>, 1,25(OH)<sub>2</sub>D<sub>3</sub> and 24,25(OH)<sub>2</sub>D<sub>3</sub> are detectable in follicular fluid. Follicular fluid concentration of the 24,25(OH)<sub>2</sub>D<sub>3</sub> metabolite was higher than corresponding serum values, while the opposite phenomenon was observed for the 1,25(OH)<sub>2</sub>D<sub>3</sub> metabolite. Local conversion is plausible as the vitamin D activating enzymes (CYP2R1 and CYP27B1) as well as the vitamin D receptor (VDR) are highly expressed in the developing follicle. Women who achieved a live birth had 29 % higher 24,25(OH)<sub>2</sub>D<sub>3</sub> and 15 % higher 25OHD<sub>3</sub> concentrations in their follicular fluid (18 ± 7.9 versus 14 ± 6.2 nmol/L, p = 0.008 and 71 ± 22 versus 62 ± 18 nmol/L, p = 0.025, respectively) compared to women not achieving a live birth. Moreover, women with a low (≤ 15 %) follicular fluid 1,25(OH)<sub>2</sub>D<sub>3</sub>/24,25(OH)<sub>2</sub>D<sub>3</sub> ratio had a higher live birth rate compared to women with a medium (16–84 %) or high (≥ 85 %) ratio (live birth rate: 53 % vs 29 % and 12 %, respectively, p = 0.032).</div></div><div><h3>Conclusion</h3><div>This study reveals that high levels of 24,25(OH)<sub>2</sub>D<sub>3</sub> and low levels of the 1,25(OH)<sub>2</sub>D<sub>3</sub>/24,25(OH)<sub>2</sub>D<sub>3</sub> ratio in follicular fluid are associated with increased live birth rates in women undergoing IVF/ICSI treatment. Conversion of vitamin D metabolites systemically or in the ovarian follicle may affect ART outcome. Further studies are warranted to support the findings from this pilot study and identify regulators of ovarian vitamin D metabolites.</div></div>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106764"},"PeriodicalIF":2.7,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143848543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purification and biochemical characterization of mutant ligand binding domain of human estrogen receptor α protein 人雌激素受体α蛋白配体结合域突变体的纯化及生化特性研究
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-15 DOI: 10.1016/j.jsbmb.2025.106763
Murugesan Palaniappan , Kurt M. Bohren
The acquisition of mutations in the estrogen receptor alpha (ERα) gene (ESR1) is a key driver in the development of resistance to current endocrine therapy in breast cancer. Clinical studies have shown that ESR1 mutations are frequently observed in patients with metastatic ER-positive breast cancer and are associated with poor survival. Activating ESR1 somatic mutations, particularly Y537S and D538G, drive estrogen-independent activities in cell-based studies and these mutant receptors are less sensitive to current endocrine therapies. Here, we describe the bacterial expression and purification of the ligand binding domains of wild-type, Y537S, and D538G human ERα proteins. The biochemical activities of these domains were confirmed by homogeneous time-resolved fluorescence and polar screen ERα competition assays. The wild-type domain binds to coactivator peptides only in the presence of the ligand estradiol, whereas the Y537S or D538G domains bind coactivator peptides spontaneously even without estradiol, with the Y537S domain showing higher affinity. Thermal shift assays showed that the mutations stabilized these domains. Our purified human ERα wild-type, Y537S, and D538G ligand binding domains recapitulate the biological activities ascribed to the full-length proteins and can therefore be used for small molecule screens that seek to discriminate between wild-type and mutant ERα.
雌激素受体α (ERα)基因(ESR1)突变的获得是乳腺癌对当前内分泌治疗产生耐药性的关键驱动因素。临床研究表明,ESR1突变常见于转移性er阳性乳腺癌患者,并与较差的生存率相关。激活ESR1体细胞突变,特别是Y537S和D538G,在基于细胞的研究中驱动雌激素非依赖性活性,这些突变受体对当前内分泌治疗不太敏感。在这里,我们描述了野生型,Y537S和D538G人ERα蛋白的配体结合域的细菌表达和纯化。这些结构域的生化活性通过均匀的时间分辨荧光和极性筛选ERα竞争试验得到证实。野生型结构域仅在配体雌二醇存在时才能与辅激活肽结合,而Y537S或D538G结构域即使在没有雌二醇的情况下也能自发地与辅激活肽结合,其中Y537S结构域具有更高的亲和力。热移分析表明突变稳定了这些结构域。我们纯化的人ERα野生型、Y537S和D538G配体结合域概括了全长蛋白的生物活性,因此可以用于小分子筛选,以寻求区分野生型和突变型ERα。
{"title":"Purification and biochemical characterization of mutant ligand binding domain of human estrogen receptor α protein","authors":"Murugesan Palaniappan ,&nbsp;Kurt M. Bohren","doi":"10.1016/j.jsbmb.2025.106763","DOIUrl":"10.1016/j.jsbmb.2025.106763","url":null,"abstract":"<div><div>The acquisition of mutations in the estrogen receptor alpha (ERα) gene (ESR1) is a key driver in the development of resistance to current endocrine therapy in breast cancer. Clinical studies have shown that ESR1 mutations are frequently observed in patients with metastatic ER-positive breast cancer and are associated with poor survival. Activating ESR1 somatic mutations, particularly Y537S and D538G, drive estrogen-independent activities in cell-based studies and these mutant receptors are less sensitive to current endocrine therapies. Here, we describe the bacterial expression and purification of the ligand binding domains of wild-type, Y537S, and D538G human ERα proteins. The biochemical activities of these domains were confirmed by homogeneous time-resolved fluorescence and polar screen ERα competition assays. The wild-type domain binds to coactivator peptides only in the presence of the ligand estradiol, whereas the Y537S or D538G domains bind coactivator peptides spontaneously even without estradiol, with the Y537S domain showing higher affinity. Thermal shift assays showed that the mutations stabilized these domains. Our purified human ERα wild-type, Y537S, and D538G ligand binding domains recapitulate the biological activities ascribed to the full-length proteins and can therefore be used for small molecule screens that seek to discriminate between wild-type and mutant ERα.</div></div>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106763"},"PeriodicalIF":2.7,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143837842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contribution of different vitamin D forms and fortified foods to vitamin D intake in Europe: A narrative review 欧洲不同形式的维生素 D 和强化食品对维生素 D 摄入量的贡献:叙述性综述
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-14 DOI: 10.1016/j.jsbmb.2025.106761
Maaike J. Bruins
In the current narrative review, the bioavailability of the main vitamin D forms is evaluated. The mean intakes and main contributing forms of vitamin D in the European diet are estimated, as well as the major contributing dietary sources. The literature is reviewed for studies reporting on the proportion of users and non-users of fortified food with vitamin D intakes below reference intakes. In addition, the availability of vitamin D-fortified prepackaged retail products and fortification levels in the European market is assessed. Previously, vitamins D2 and D3 forms were considered the primary forms in the diet. Recent analytical methods suggest that dietary 25(OH)D3, when adjusted for higher bioequivalence, significantly contributes to total vitamin D intakes. When also considering 25(OH)D3 from foods, the estimated vitamin D intake from an average European diet was 3.8 µg/d of total Vitamin D Equivalents: vitamin D3, vitamin D2 and 25(OH)D3, contributing about 71 %, 2 %, and 27 %, respectively. Animal foods, fortified fats and spreads contributed most to total intakes. Literature suggests that 94–100 % of Europeans aged ≥ 13 y fail to meet the vitamin D reference intake of 10 µg/d. About 98–100 % of vitamin D-fortified food users and 99–100 % of non-users in the UK and Netherlands consumed less than 10 µg/d of vitamin D. About 1.2 % of prepackaged foods and drinks were voluntary fortified with vitamin D, margarine and plant-based drinks providing most of the daily vitamin D. Encouraging fortification and other strategies may support closing the gap between current and recommended vitamin D intakes.
本综述对主要维生素 D 形式的生物利用率进行了评估。估算了欧洲人膳食中维生素 D 的平均摄入量和主要构成形式,以及主要的膳食来源。文献回顾了有关维生素 D 摄入量低于参考摄入量的强化食品使用者和非使用者比例的研究报告。此外,还评估了欧洲市场上维生素 D 强化预包装零售产品的供应情况和强化水平。以前,维生素 D2 和 D3 被认为是膳食中的主要形式。最近的分析方法表明,膳食中的 25(OH)D3(根据更高的生物等效性进行调整后)对维生素 D 的总摄入量有显著贡献。如果同时考虑食物中的 25(OH)D3,估计欧洲人平均每天从膳食中摄入的维生素 D 总量为 3.8 微克:维生素 D3、维生素 D2 和 25(OH)D3,分别占 71%、2% 和 27%。动物性食品、强化脂肪和涂抹酱对总摄入量的贡献最大。文献表明,94%-100% 年龄≥ 13 岁的欧洲人的维生素 D 参考摄入量达不到 10 µg/d。在英国和荷兰,约 98-100% 的维生素 D 强化食品使用者和 99-100% 的非使用者的维生素 D 摄入量低于 10 µg/d。约 1.2% 的预包装食品和饮料自愿添加了维生素 D,人造奶油和植物饮料提供了每日维生素 D 的大部分。
{"title":"Contribution of different vitamin D forms and fortified foods to vitamin D intake in Europe: A narrative review","authors":"Maaike J. Bruins","doi":"10.1016/j.jsbmb.2025.106761","DOIUrl":"10.1016/j.jsbmb.2025.106761","url":null,"abstract":"<div><div>In the current narrative review, the bioavailability of the main vitamin D forms is evaluated. The mean intakes and main contributing forms of vitamin D in the European diet are estimated, as well as the major contributing dietary sources. The literature is reviewed for studies reporting on the proportion of users and non-users of fortified food with vitamin D intakes below reference intakes. In addition, the availability of vitamin D-fortified prepackaged retail products and fortification levels in the European market is assessed. Previously, vitamins D2 and D3 forms were considered the primary forms in the diet. Recent analytical methods suggest that dietary 25(OH)D3, when adjusted for higher bioequivalence, significantly contributes to total vitamin D intakes. When also considering 25(OH)D3 from foods, the estimated vitamin D intake from an average European diet was 3.8 µg/d of total Vitamin D Equivalents: vitamin D3, vitamin D2 and 25(OH)D3, contributing about 71 %, 2 %, and 27 %, respectively. Animal foods, fortified fats and spreads contributed most to total intakes. Literature suggests that 94–100 % of Europeans aged ≥ 13 y fail to meet the vitamin D reference intake of 10 µg/d. About 98–100 % of vitamin D-fortified food users and 99–100 % of non-users in the UK and Netherlands consumed less than 10 µg/d of vitamin D. About 1.2 % of prepackaged foods and drinks were voluntary fortified with vitamin D, margarine and plant-based drinks providing most of the daily vitamin D. Encouraging fortification and other strategies may support closing the gap between current and recommended vitamin D intakes.</div></div>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106761"},"PeriodicalIF":2.7,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143829828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The distinctive P450 oxidoreductase (PORD) urinary steroid metabolome in the first week of life: Report of three cases with severe disorder 出生第一周的P450氧化还原酶(PORD)尿类固醇代谢组:三例严重疾病的报告
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-11 DOI: 10.1016/j.jsbmb.2025.106760
E.S. Baranowski , J. Idkowiak , J. Waterson , A. D’Harlingue , A.H. Olney , H.E. Ivison , B.A. Hughes , J.W. Mueller , W. Arlt , C.H.L. Shackleton
P450 oxidoreductase (POR) facilitates electron flux to type 2 microsomal P450 cytochrome enzymes (CYPs), including the adrenal steroidogenic enzymes CYP17A1 and CYP21A2. Due to the combined impairment of these enzymes, POR deficiency (PORD), an autosomal recessive condition, results in congenital adrenal hyperplasia characterised by combined glucocorticoid and postnatal sex steroid deficiency. This study focuses on urinary steroid excretion in infants affected by PORD in the first week of life. We report on three neonatal PORD cases from two families. One family had two affected babies born three years apart who were stillborn and first-day deceased, respectively. DNA sequencing revealed a homozygous 3 bp deletion in exon six leading to an glutamic acid deletion (p.[Glu217del]). Bladder contents were obtained from the stillborn baby, and excreted urine was obtained from the second baby. In a second family, their second affected newborn, antenatally diagnosed carrying the common homozygous p.(Ala287Pro) mutation, had urine collected daily during the first week of life. Steroid excretions were quantified by gas chromatography-mass spectrometry (GC-MS). The birth-day excretions were very similar in all babies. Most notable and unusual was a large excretion of unmetabolised corticosterone, suggesting inhibited catabolism to allow maximum active gluco- and mineralocorticoid availability at birth. Because CYP3A7 (16α-hydroxylase) requires POR, there was an almost complete absence of usually dominant 3β-hydroxy-Δ5 steroids (16α-OH-DHEA and 16α-OH-pregnenolone) and the usually characteristic precursor pregnenolone metabolite 5-pregnene-3β,20α-diol (pregnenediol, 5PD). In the baby sequentially studied over a week, we observed gradual maturation to the typical and familiar PORD neonatal metabolome. At the end of the period, the minimally catabolised corticosterone had diminished, and steroid excretion was completely dominated by 5PD, excreted as both mono- and disulphate conjugates. Whether this metabolome is distinctive of all PORD infants, not just those with severe manifestation, is not known. On the first day of life, standard diagnostic markers are compromised due to fetal-placental-maternal contribution and unique neonatal steroid metabolism. However, the Day 1 PORD steroid metabolome remains distinctive, and we propose using additional biochemical markers reflective of the near complete reduction of POR-dependent CYP3A7 (16α-hydroxylase) activity to improve diagnostic yield.
P450氧化还原酶(POR)促进电子通量到2型微粒体P450细胞色素酶(CYPs),包括肾上腺甾体生成酶CYP17A1和CYP21A2。由于这些酶的联合损伤,POR缺乏症(PORD),一种常染色体隐性遗传病,导致先天性肾上腺增生,其特征是糖皮质激素和产后性类固醇缺乏症。本研究的重点是在出生后第一周受PORD影响的婴儿的尿类固醇排泄。我们报告来自两个家庭的三例新生儿PORD病例。一个家庭有两个相隔三年出生的受影响婴儿,分别是死产和第一天死亡。DNA测序显示,6号外显子纯合子3 bp缺失导致谷氨酸缺失(p.[Glu217del])。膀胱内容物取自死产婴儿,排泄尿液取自第二个婴儿。在第二个家庭中,他们的第二个受影响的新生儿,产前诊断携带常见的纯合子p.(Ala287Pro)突变,在出生后的第一周每天收集尿液。采用气相色谱-质谱联用(GC-MS)法测定类固醇排泄量。所有婴儿出生时的排泄物都非常相似。最值得注意和最不寻常的是大量未代谢皮质酮的排泄,这表明抑制分解代谢使出生时最大限度地获得活性糖皮质激素和矿皮质激素。由于CYP3A7 (16α-羟化酶)需要POR,因此几乎完全没有通常占主导地位的3β-羟基-Δ5类固醇(16α-OH-DHEA和16α- oh -孕烯醇酮)和通常具有特征的前体孕烯醇酮代谢物5-孕烯-3β,20α-二醇(孕烯二醇,5PD)。在连续一周的研究中,我们观察到婴儿逐渐成熟为典型和熟悉的PORD新生儿代谢组。在这段时间结束时,最低分解代谢的皮质酮已经减少,类固醇排泄完全由5PD主导,以单硫酸盐和二硫酸盐偶联物的形式排出。这种代谢组是否在所有PORD婴儿中都是独特的,而不仅仅是那些表现严重的婴儿,目前还不清楚。在生命的第一天,由于胎儿-胎盘-母体的贡献和独特的新生儿类固醇代谢,标准诊断标志物受到损害。然而,第1天的PORD类固醇代谢组仍然是独特的,我们建议使用其他生化标记,反映por依赖性CYP3A7 (16α-羟化酶)活性几乎完全降低,以提高诊断率。
{"title":"The distinctive P450 oxidoreductase (PORD) urinary steroid metabolome in the first week of life: Report of three cases with severe disorder","authors":"E.S. Baranowski ,&nbsp;J. Idkowiak ,&nbsp;J. Waterson ,&nbsp;A. D’Harlingue ,&nbsp;A.H. Olney ,&nbsp;H.E. Ivison ,&nbsp;B.A. Hughes ,&nbsp;J.W. Mueller ,&nbsp;W. Arlt ,&nbsp;C.H.L. Shackleton","doi":"10.1016/j.jsbmb.2025.106760","DOIUrl":"10.1016/j.jsbmb.2025.106760","url":null,"abstract":"<div><div>P450 oxidoreductase (POR) facilitates electron flux to type 2 microsomal P450 cytochrome enzymes (CYPs), including the adrenal steroidogenic enzymes CYP17A1 and CYP21A2. Due to the combined impairment of these enzymes, POR deficiency (PORD), an autosomal recessive condition, results in congenital adrenal hyperplasia characterised by combined glucocorticoid and postnatal sex steroid deficiency. This study focuses on urinary steroid excretion in infants affected by PORD in the first week of life. We report on three neonatal PORD cases from two families. One family had two affected babies born three years apart who were stillborn and first-day deceased, respectively. DNA sequencing revealed a homozygous 3 bp deletion in exon six leading to an glutamic acid deletion (p.[Glu217del]). Bladder contents were obtained from the stillborn baby, and excreted urine was obtained from the second baby. In a second family, their second affected newborn, antenatally diagnosed carrying the common homozygous p.(Ala287Pro) mutation, had urine collected daily during the first week of life. Steroid excretions were quantified by gas chromatography-mass spectrometry (GC-MS). The birth-day excretions were very similar in all babies. Most notable and unusual was a large excretion of unmetabolised corticosterone, suggesting inhibited catabolism to allow maximum active gluco- and mineralocorticoid availability at birth. Because CYP3A7 (16α-hydroxylase) requires POR, there was an almost complete absence of usually dominant 3β-hydroxy-Δ<sup>5</sup> steroids (16α-OH-DHEA and 16α-OH-pregnenolone) and the usually characteristic precursor pregnenolone metabolite 5-pregnene-3β,20α-diol (pregnenediol, 5PD). In the baby sequentially studied over a week, we observed gradual maturation to the typical and familiar PORD neonatal metabolome. At the end of the period, the minimally catabolised corticosterone had diminished, and steroid excretion was completely dominated by 5PD, excreted as both mono- and disulphate conjugates. Whether this metabolome is distinctive of all PORD infants, not just those with severe manifestation, is not known. On the first day of life, standard diagnostic markers are compromised due to fetal-placental-maternal contribution and unique neonatal steroid metabolism. However, the Day 1 PORD steroid metabolome remains distinctive, and we propose using additional biochemical markers reflective of the near complete reduction of POR-dependent CYP3A7 (16α-hydroxylase) activity to improve diagnostic yield.</div></div>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106760"},"PeriodicalIF":2.7,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143837841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive survey of disease-causing missense mutations of the cholesterol synthesis enzyme NSDHL: Low temperature and a chemical chaperone rescue low protein expression of select mutants 胆固醇合成酶NSDHL致病错义突变的综合研究:低温和化学伴侣拯救选择突变体的低蛋白表达
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-11 DOI: 10.1016/j.jsbmb.2025.106758
Nicole M. Fenton, Laura J. Sharpe, Dylan M. Fitzsimmons, Isabelle M. Capell-Hattam, Andrew J. Brown
Cholesterol is essential to human life. Perturbations to any of the 22 cholesterol synthesis enzymes can lead to devastating developmental diseases. Each enzyme is exquisitely regulated both transcriptionally and post-translationally, playing a critical role in providing cholesterol to cells. We examined 13 missense mutations and one deletion mutation in the cholesterol synthesis enzyme NSDHL (NAD(P) Dependent Steroid Dehydrogenase-Like), known to cause the X-linked developmental disorders CHILD (congenital hemidysplasia with ichthyosiform erythroderma and limb defects) syndrome and CK syndrome. Little is known about the effect of these missense mutations on the stability and function of NSDHL. Here we show that protein expression levels were low for all mutants, but some could be rescued by a lower temperature (30°C vs. 37°C) and/or the chemical chaperone glycerol. Additionally, heat shock proteins 70 and 90 are needed for optimal NSDHL protein expression suggesting that disease mutations in NSDHL may interfere with this interaction, perhaps during translation resulting in lower protein synthesis. Our findings that these disease-causing mutations reduce NSDHL protein expression, but some respond to lower temperature and/or the chemical chaperone glycerol, can help inform future treatments for CHILD and CK syndrome.
胆固醇对人类生命至关重要。22 种胆固醇合成酶中的任何一种受到干扰,都会导致毁灭性的发育疾病。每种酶都受到转录和翻译后的严格调控,在为细胞提供胆固醇方面发挥着关键作用。我们研究了胆固醇合成酶 NSDHL(NAD(P) Dependent Steroid Dehydrogenase-Like)中的 13 个错义突变和 1 个缺失突变,已知这些突变可导致 X 连锁发育疾病 CHILD(先天性半身不遂伴鱼鳞状红斑和肢体缺陷)综合征和 CK 综合征。人们对这些错义突变对 NSDHL 的稳定性和功能的影响知之甚少。在这里,我们发现所有突变体的蛋白质表达水平都很低,但有些突变体可以通过较低的温度(30°C vs. 37°C)和/或化学伴侣甘油来挽救。此外,NSDHL 蛋白的最佳表达需要热休克蛋白 70 和 90,这表明 NSDHL 中的疾病突变可能会干扰这种相互作用,也许是在翻译过程中导致蛋白质合成降低。我们的发现表明,这些致病突变会降低 NSDHL 蛋白的表达,但有些突变会对较低的温度和/或化学伴侣甘油产生反应,这有助于为 CHILD 和 CK 综合征的未来治疗提供依据。
{"title":"Comprehensive survey of disease-causing missense mutations of the cholesterol synthesis enzyme NSDHL: Low temperature and a chemical chaperone rescue low protein expression of select mutants","authors":"Nicole M. Fenton,&nbsp;Laura J. Sharpe,&nbsp;Dylan M. Fitzsimmons,&nbsp;Isabelle M. Capell-Hattam,&nbsp;Andrew J. Brown","doi":"10.1016/j.jsbmb.2025.106758","DOIUrl":"10.1016/j.jsbmb.2025.106758","url":null,"abstract":"<div><div>Cholesterol is essential to human life. Perturbations to any of the 22 cholesterol synthesis enzymes can lead to devastating developmental diseases. Each enzyme is exquisitely regulated both transcriptionally and post-translationally, playing a critical role in providing cholesterol to cells. We examined 13 missense mutations and one deletion mutation in the cholesterol synthesis enzyme NSDHL (NAD(P) Dependent Steroid Dehydrogenase-Like), known to cause the X-linked developmental disorders CHILD (congenital hemidysplasia with ichthyosiform erythroderma and limb defects) syndrome and CK syndrome. Little is known about the effect of these missense mutations on the stability and function of NSDHL. Here we show that protein expression levels were low for all mutants, but some could be rescued by a lower temperature (30°C <em>vs.</em> 37°C) and/or the chemical chaperone glycerol. Additionally, heat shock proteins 70 and 90 are needed for optimal NSDHL protein expression suggesting that disease mutations in NSDHL may interfere with this interaction, perhaps during translation resulting in lower protein synthesis. Our findings that these disease-causing mutations reduce NSDHL protein expression, but some respond to lower temperature and/or the chemical chaperone glycerol, can help inform future treatments for CHILD and CK syndrome.</div></div>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106758"},"PeriodicalIF":2.7,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143835050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High reliance on fortified foods when optimizing diets of adolescents in Sweden for adequate vitamin D intake and climate sustainability 在优化瑞典青少年的饮食以获得充足的维生素D摄入量和气候可持续性时,高度依赖强化食品
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-07 DOI: 10.1016/j.jsbmb.2025.106759
André Hesselink , Anna Winkvist , Anna Karin Lindroos , Patricia Eustachio Colombo , Linnea Bärebring , Elinor Hallström , Hanna Augustin
The global food system contributes roughly one-third of global greenhouse gas emissions (GHGEs) making shifts towards more sustainable food consumption an imperative. Such diets also need to factor in nutrient requirements and cultural acceptability. Our aim was to simulate dietary changes for adolescents in Sweden to achieve the recommended intake (RI) for vitamin D while factoring in additional nutrients, cultural acceptability and keeping the diet within planetary boundaries for climate change. A baseline diet was estimated from Sweden’s national dietary survey Riksmaten Adolescents 2016–17 (n = 3099, ages 11–18 years), which provided food intake via two 24-hour recalls. Intake data were linked to the Swedish Food Agency’s food composition database and GHGE estimates from the Research Institutes of Sweden’s (RISE) Food Climate Database. Linear programming was used to optimize the baseline diet to meet the RI for vitamin D (10 µg/day), reduce GHGEs to ≤ 1.7 kg CO2-equivalents/person/day, and minimize dietary changes from baseline to factor in cultural acceptability. A second optimization included 25 additional nutrients requirements. Both optimized diets met their respective requirements reducing GHGEs by 54 % but relied heavily on milk and yoghurt (fortified by law), which provided > 60 % of vitamin D intake. Both diets also required major shifts toward plant-based foods and the second optimization demanded a five-fold greater change in diet from baseline compared to first optimization. Results suggest that adolescents in Sweden can achieve RIs for vitamin D and other nutrients while greatly reducing diet-related GHGEs, though cultural acceptability may be a challenge.
全球粮食系统约占全球温室气体排放量的三分之一,因此向更可持续的粮食消费转变势在必行。这种饮食还需要考虑营养需求和文化可接受性。我们的目的是模拟瑞典青少年的饮食变化,以达到维生素D的推荐摄入量(RI),同时考虑到额外的营养素,文化可接受性,并将饮食保持在气候变化的全球范围内。基线饮食来自瑞典国家饮食调查Riksmaten青少年2016-17 (n = 3099,年龄11-18岁),该调查通过两次24小时回忆提供食物摄入量。摄入数据与瑞典食品机构的食品成分数据库和瑞典研究所(RISE)食品气候数据库的温室气体排放估算相关联。使用线性规划优化基线饮食,以满足维生素D的RI(10 µg/day),将温室气体减少到≤ 1.7 kg co2当量/人/day,并最大限度地减少基线饮食变化,以考虑文化可接受性。第二个优化包括25个额外的营养素需求。两种优化的饮食都达到了各自减少温室气体排放的要求,减少了54% %,但严重依赖牛奶和酸奶(法律强化),它们提供了 60% %的维生素D摄入量。这两种饮食都需要向植物性食物的重大转变,与第一次优化相比,第二次优化需要的饮食变化是基线的五倍。结果表明,瑞典的青少年可以在大大减少与饮食有关的温室气体的同时实现维生素D和其他营养素的RIs,尽管文化上的可接受性可能是一个挑战。
{"title":"High reliance on fortified foods when optimizing diets of adolescents in Sweden for adequate vitamin D intake and climate sustainability","authors":"André Hesselink ,&nbsp;Anna Winkvist ,&nbsp;Anna Karin Lindroos ,&nbsp;Patricia Eustachio Colombo ,&nbsp;Linnea Bärebring ,&nbsp;Elinor Hallström ,&nbsp;Hanna Augustin","doi":"10.1016/j.jsbmb.2025.106759","DOIUrl":"10.1016/j.jsbmb.2025.106759","url":null,"abstract":"<div><div>The global food system contributes roughly one-third of global greenhouse gas emissions (GHGEs) making shifts towards more sustainable food consumption an imperative. Such diets also need to factor in nutrient requirements and cultural acceptability. Our aim was to simulate dietary changes for adolescents in Sweden to achieve the recommended intake (RI) for vitamin D while factoring in additional nutrients, cultural acceptability and keeping the diet within planetary boundaries for climate change. A baseline diet was estimated from Sweden’s national dietary survey Riksmaten Adolescents 2016–17 (n = 3099, ages 11–18 years), which provided food intake via two 24-hour recalls. Intake data were linked to the Swedish Food Agency’s food composition database and GHGE estimates from the Research Institutes of Sweden’s (RISE) Food Climate Database. Linear programming was used to optimize the baseline diet to meet the RI for vitamin D (10 µg/day), reduce GHGEs to ≤ 1.7 kg CO<sub>2</sub>-equivalents/person/day, and minimize dietary changes from baseline to factor in cultural acceptability. A second optimization included 25 additional nutrients requirements. Both optimized diets met their respective requirements reducing GHGEs by 54 % but relied heavily on milk and yoghurt (fortified by law), which provided &gt; 60 % of vitamin D intake. Both diets also required major shifts toward plant-based foods and the second optimization demanded a five-fold greater change in diet from baseline compared to first optimization. Results suggest that adolescents in Sweden can achieve RIs for vitamin D and other nutrients while greatly reducing diet-related GHGEs, though cultural acceptability may be a challenge.</div></div>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106759"},"PeriodicalIF":2.7,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143826211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of A. paeoniifolius extracts on bone growth and osteoporosis via inhibiting RANKL-mediated pathway 芍药提取物通过抑制rankl介导通路对骨生长和骨质疏松的影响。
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-05 DOI: 10.1016/j.jsbmb.2025.106746
Mrinal Sanaye , Maria Alva , Tejal Wani , Arindam Banerjee , Rajasekaran R
Osteoporotic fractures are commonly observed in postmenopausal women. The major risk factor involved is estrogen deficiency. Phytoestrogens, structurally identical to 17-estradiol, have been shown to decrease bone turnover markers, increase bone mineral density, and provide protection against osteoporosis. The present study involves probing the molecular mechanism of Amorphophallus paeoniifolius (AP) rich in phytoestrogens viz kaempferol, rutin, quercetin, and gallic acid, as some therapeutic moieties in the treatment of osteoporosis. The study involves extraction of AP followed by MTT assay for cytotoxicity, and RT-PCR for evaluating the mRNA expression of RANKL, ALP, IL-6, Osteopontin (OPN), and Osteocalcin (OCN ) and western blot analysis of RANKL, along with bone mineralization assay. In the MTT assay, AP extracts showed biocompatibility in both MG-63 and UMR-106, with downregulation of osteoclast differentiation factors RANKL, and IL-6 and upregulation of osteoblastic markers OPN, OCN , and ALP through RT-PCR analysis at 50 μg/ml. In western Blot analysis, decreased protein expression of RANKL indicates reduced bone resorption. A significant increase in Alizarin red dye staining intensity during treatment confirms the progression of calcium deposition, thereby ensuring bone remineralization. The study reveals that AP, promotes osteoblast differentiation, bone re-mineralization, and re-calcification by the downregulation of the RANKL-mediated pathway, suggesting potential therapeutic efficacy for the treatment of post-menopausal osteoporosis.
骨质疏松性骨折常见于绝经后妇女。主要的危险因素是雌激素缺乏。植物雌激素,结构上与17-雌二醇相同,已被证明可以减少骨转换标志物,增加骨矿物质密度,并提供预防骨质疏松症的保护。本研究探讨了紫穗槐(Amorphophallus paeoniiolius, AP)富含山奈酚、芦丁、槲皮素和没食子酸等植物雌激素,作为治疗骨质疏松症的治疗成分的分子机制。本研究包括提取AP,然后用MTT法检测细胞毒性,RT-PCR法检测RANKL、ALP、IL-6、骨桥蛋白(OPN)和骨钙素(OCN) mRNA的表达,以及RANKL的western blot分析,以及骨矿化试验。在MTT实验中,AP提取物在MG-63和UMR-106中均表现出生物相容性,在50μg/ml的浓度下,通过RT-PCR分析,AP提取物可下调破骨细胞分化因子RANKL和IL-6,上调成骨细胞标志物OPN、OCN和ALP。western Blot结果显示,RANKL蛋白表达降低表明骨吸收减少。治疗期间茜素红染色强度的显著增加证实了钙沉积的进展,从而确保了骨再矿化。研究发现,AP通过下调rankl介导的通路促进成骨细胞分化、骨再矿化和再钙化,提示其治疗绝经后骨质疏松的潜在疗效。
{"title":"Effect of A. paeoniifolius extracts on bone growth and osteoporosis via inhibiting RANKL-mediated pathway","authors":"Mrinal Sanaye ,&nbsp;Maria Alva ,&nbsp;Tejal Wani ,&nbsp;Arindam Banerjee ,&nbsp;Rajasekaran R","doi":"10.1016/j.jsbmb.2025.106746","DOIUrl":"10.1016/j.jsbmb.2025.106746","url":null,"abstract":"<div><div>Osteoporotic fractures are commonly observed in postmenopausal women. The major risk factor involved is estrogen deficiency. Phytoestrogens, structurally identical to 17-estradiol, have been shown to decrease bone turnover markers, increase bone mineral density, and provide protection against osteoporosis. The present study involves probing the molecular mechanism of <em>Amorphophallus paeoniifolius (</em>AP<em>)</em> rich in phytoestrogens viz kaempferol, rutin, quercetin, and gallic acid, as some therapeutic moieties in the treatment of osteoporosis. The study involves extraction of AP followed by MTT assay for cytotoxicity, and RT-PCR for evaluating the mRNA expression of <em>RANKL</em>, <em>ALP</em>, <em>IL-6</em>, Osteopontin (<em>OPN</em>), and Osteocalcin (<em>OCN</em> <!-->) and western blot analysis of <em>RANKL</em>, along with bone mineralization assay. In the MTT assay, AP extracts showed biocompatibility in both MG-63 and UMR-106, with downregulation of osteoclast differentiation factors <em>RANKL</em>, and <em>IL-6</em> and upregulation of osteoblastic markers <em>OPN</em>, <em>OCN</em> <!-->, and <em>ALP</em> through RT-PCR analysis at 50 μg/ml. In western Blot analysis, decreased protein expression of RANKL indicates reduced bone resorption. A significant increase in Alizarin red dye staining intensity during treatment confirms the progression of calcium deposition, thereby ensuring bone remineralization. The study reveals that AP, promotes osteoblast differentiation, bone re-mineralization, and re-calcification by the downregulation of the <em>RANKL</em>-mediated pathway, suggesting potential therapeutic efficacy for the treatment of post-menopausal osteoporosis.</div></div>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106746"},"PeriodicalIF":2.7,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143804763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zingerone modulates the circulating steroids hormone levels and testicular steroidogenic markers expression in mice: An in vivo and in silico study 姜酮调节小鼠循环类固醇激素水平和睾丸类固醇生成标记物表达:体内和计算机研究
IF 2.7 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-04-04 DOI: 10.1016/j.jsbmb.2025.106748
Miti Jerang , Guruswami Gurusubramanian , Ved Prakash Singh , Vikas Kumar Roy
Zingerone (4-(4-hydroxy-3-methoxyphenyl)-2-butanone) is a phytochemical with potent anti-inflammatory and antioxidant properties. It has been shown that zingerone protects testis under pathological conditions by its antioxidant and anti-inflammatory effects. However, there is no direct evidence that zingerone specifically affects the testicular steroidogenesis in normal conditions. Therefore, in this study, we have investigated the effects of zingerone on testicular steroidogenesis by using in vivo and silico approaches. The mice were divided into four groups: Control, 10, 25, and 50 mg/kg dosages of zingerone, which were administered orally for 35 days. It was observed that zingerone treatment modulates both circulating hormone levels and the expression of steroidogenic protein markers. Specifically, the higher doses of zingerone resulted in an increase in the circulating estrogen and androstenedione levels, while progesterone, testosterone, and follicle-stimulating hormone levels were reduced. Further, no significant change was observed in the circulating LH level. The higher doses of zingerone resulted in an increased expression and localisation of 3βHSD, CYP19A1, LHR and decreased expression and localisation of StAR, CYP11A1, and 17βHSD protein. Our silico studies showed that the steroidogenic proteins (CYP11A1, 3βHSD, 17βHSD) when double docked with zingerone alongside its native ligands (cholesterol, pregnenolone, androstenedione) showed an increase in the binding affinity. In contrast, StAR, CYP19A1 when double docked with zingerone and its native ligands exhibited a lesser binding affinity compared to when these proteins were single docked with their native ligand and zingerone. In conclusion, in vivo study showed zingerone stimulates androstenedione, estrogen secretion and up-regulates the expression of CYP19A1, LHR and 3βHSD proteins, whereas it down-regulates the expression of StAR, CYP11A1 and 17βHSD proteins and circulating testosterone, progesterone, follicle-stimulating hormone levels. Furthermore, in silico study has also shown the binding affinities of zingerone with the steroidogenic markers. Thus, zingerone has modulatory effects on testicular steroid biosynthesis in normal mice.
姜酮(4-(4-羟基-3-甲氧基苯基)-2-丁酮)是一种具有有效抗炎和抗氧化特性的植物化学物质。研究表明,生姜酮通过其抗氧化和抗炎作用在病理条件下保护睾丸。然而,没有直接证据表明生姜酮在正常情况下特别影响睾丸甾体生成。因此,在本研究中,我们采用体内法和硅法研究了生姜酮对睾丸甾体生成的影响。将小鼠分为4组:对照组、10、25、50 mg/kg剂量组,连续口服35 d。观察到姜酮处理可调节循环激素水平和类固醇蛋白标记物的表达。具体来说,高剂量的姜酮导致循环中的雌激素和雄烯二酮水平增加,而孕酮、睾酮和促卵泡激素水平降低。此外,循环LH水平未见明显变化。高剂量姜酮导致3βHSD、CYP19A1、LHR蛋白的表达和定位增加,而StAR、CYP11A1和17βHSD蛋白的表达和定位降低。我们的硅研究表明,当与生姜酮及其天然配体(胆固醇、孕烯醇酮、雄烯二酮)双对接时,类固醇原蛋白(CYP11A1、3βHSD、17βHSD)的结合亲和力增加。相比之下,StAR、CYP19A1与生姜酮及其天然配体双对接时,与这些蛋白与其天然配体和生姜酮单对接时,其结合亲和力较低。综上所述,体内实验表明,生姜酮刺激雄烯二酮、雌激素分泌,上调CYP19A1、LHR、3βHSD蛋白表达,下调StAR、CYP11A1、17βHSD蛋白表达及循环睾酮、孕酮、促卵泡激素水平。此外,在硅片上的研究也显示了姜酮与甾体生成标记物的结合亲和力。因此,姜酮对正常小鼠睾丸类固醇生物合成具有调节作用。
{"title":"Zingerone modulates the circulating steroids hormone levels and testicular steroidogenic markers expression in mice: An in vivo and in silico study","authors":"Miti Jerang ,&nbsp;Guruswami Gurusubramanian ,&nbsp;Ved Prakash Singh ,&nbsp;Vikas Kumar Roy","doi":"10.1016/j.jsbmb.2025.106748","DOIUrl":"10.1016/j.jsbmb.2025.106748","url":null,"abstract":"<div><div>Zingerone (4-(4-hydroxy-3-methoxyphenyl)-2-butanone) is a phytochemical with potent anti-inflammatory and antioxidant properties. It has been shown that zingerone protects testis under pathological conditions by its antioxidant and anti-inflammatory effects. However, there is no direct evidence that zingerone specifically affects the testicular steroidogenesis in normal conditions. Therefore, in this study, we have investigated the effects of zingerone on testicular steroidogenesis by using in vivo and silico approaches. The mice were divided into four groups: Control, 10, 25, and 50 mg/kg dosages of zingerone, which were administered orally for 35 days. It was observed that zingerone treatment modulates both circulating hormone levels and the expression of steroidogenic protein markers. Specifically, the higher doses of zingerone resulted in an increase in the circulating estrogen and androstenedione levels, while progesterone, testosterone, and follicle-stimulating hormone levels were reduced. Further, no significant change was observed in the circulating LH level. The higher doses of zingerone resulted in an increased expression and localisation of 3βHSD, CYP19A1, LHR and decreased expression and localisation of StAR, CYP11A1, and 17βHSD protein. Our silico studies showed that the steroidogenic proteins (CYP11A1, 3βHSD, 17βHSD) when double docked with zingerone alongside its native ligands (cholesterol, pregnenolone, androstenedione) showed an increase in the binding affinity. In contrast, StAR, CYP19A1 when double docked with zingerone and its native ligands exhibited a lesser binding affinity compared to when these proteins were single docked with their native ligand and zingerone. In conclusion, in vivo study showed zingerone stimulates androstenedione, estrogen secretion and up-regulates the expression of CYP19A1, LHR and 3βHSD proteins, whereas it down-regulates the expression of StAR, CYP11A1 and 17βHSD proteins and circulating testosterone, progesterone, follicle-stimulating hormone levels. Furthermore, in silico study has also shown the binding affinities of zingerone with the steroidogenic markers. Thus, zingerone has modulatory effects on testicular steroid biosynthesis in normal mice.</div></div>","PeriodicalId":51106,"journal":{"name":"Journal of Steroid Biochemistry and Molecular Biology","volume":"251 ","pages":"Article 106748"},"PeriodicalIF":2.7,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143791891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Steroid Biochemistry and Molecular Biology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1